{
    "ticker": "DARE",
    "name": " Dare Bioscience, Inc.",
    "description": "Dare Bioscience, Inc. is a biopharmaceutical company focused on the development of innovative products for women's health. Founded in 2015 and headquartered in San Diego, California, Dare is committed to addressing unmet medical needs in the area of women's reproductive health. The company's pipeline includes several product candidates aimed at improving the treatment options available to women in various stages of life, from contraception to menopause. Dare's lead product candidate, DARE-BV, is a treatment for bacterial vaginosis, a common vaginal infection that can cause significant discomfort and complications. The company's innovative approach leverages advanced drug delivery technologies to provide effective solutions that are both safe and convenient for patients. Dare is also actively engaged in clinical trials to evaluate the efficacy and safety of its products, aiming to bring new therapies to market that empower women and enhance their quality of life. With a strong focus on research and development, Dare Bioscience is poised to make a significant impact in the field of women's health.",
    "industry": [
        "Biopharmaceuticals",
        "Healthcare"
    ],
    "headquarters": "San Diego, California, USA",
    "founded": "2015",
    "website": "https://www.darebioscience.com",
    "ceo": "Samantha Stainthorpe",
    "social_media": {
        "twitter": "https://twitter.com/DareBioscience",
        "linkedin": "https://www.linkedin.com/company/dare-bioscience/"
    },
    "investor_relations": "https://investors.darebioscience.com",
    "key_executives": [
        {
            "name": "Samantha Stainthorpe",
            "position": "CEO"
        },
        {
            "name": "Katherine A. S. H. H. Campbell",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Women's Health Products",
            "products": [
                "DARE-BV",
                "DARE-PEG"
            ]
        }
    ],
    "seo": {
        "meta_title": "Dare Bioscience, Inc. | Women's Health Innovations",
        "meta_description": "Explore Dare Bioscience, Inc., a leader in women's health biopharmaceuticals, dedicated to developing innovative therapies for women's reproductive health.",
        "keywords": [
            "Dare Bioscience",
            "Women's Health",
            "Biopharmaceuticals",
            "DARE-BV",
            "Healthcare Innovation"
        ]
    },
    "faq": [
        {
            "question": "What does Dare Bioscience focus on?",
            "answer": "Dare Bioscience focuses on developing innovative products for women's health."
        },
        {
            "question": "Who is the CEO of Dare Bioscience?",
            "answer": "Samantha Stainthorpe is the CEO of Dare Bioscience, Inc."
        },
        {
            "question": "Where is Dare Bioscience headquartered?",
            "answer": "Dare Bioscience is headquartered in San Diego, California, USA."
        },
        {
            "question": "What are some of Dare's main products?",
            "answer": "Dare's main products include DARE-BV, a treatment for bacterial vaginosis."
        },
        {
            "question": "When was Dare Bioscience founded?",
            "answer": "Dare Bioscience was founded in 2015."
        }
    ],
    "competitors": [
        "PGNY",
        "FBIO",
        "CFRX"
    ],
    "related_stocks": [
        "AMGN",
        "VRTX",
        "GILD",
        "BIIB"
    ]
}